Fig. 2
The number of reported cases of three CDK4/6 inhibitors-induced musculoskeletal adverse events from 2015 to 2023
Fig. 2 | BMC Pharmacology and Toxicology
The number of reported cases of three CDK4/6 inhibitors-induced musculoskeletal adverse events from 2015 to 2023